Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002135:Calcium-Binding Proteins / Q000096:biosynthesis / Q000187:drug effects; D000252:Calcium-Transporting ATPases / Q000096:biosynthesis / Q000187:drug effects; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D017868:Cyclic AMP-Dependent Protein Kinases / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000737:chemistry* / Q000473:pathology*; D018995:Myosin Heavy Chains / Q000096:biosynthesis / Q000187:drug effects; D020097:Natriuretic Peptide, Brain / Q000097:blood / Q000187:drug effects; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects / Q000378:metabolism; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D019831:Sodium-Calcium Exchanger / Q000187:drug effects / Q000378:metabolism; D013318:Stroke Volume / Q000187:drug effects; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects; D051552:beta-Adrenergic Receptor Kinases; D000099211:Phospholamban
D000319:Adrenergic beta-Antagonists; D015415:Biomarkers; D002135:Calcium-Binding Proteins; D000252:Calcium-Transporting ATPases; D017868:Cyclic AMP-Dependent Protein Kinases; D018995:Myosin Heavy Chains; D020097:Natriuretic Peptide, Brain; D012333:RNA, Messenger; D019837:Ryanodine Receptor Calcium Release Channel; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D019831:Sodium-Calcium Exchanger; D051552:beta-Adrenergic Receptor Kinases; D000099211:Phospholamban